Who owns Seres Therapeutics Inc?
- Ticker: MCRB
- CUSIP Number: 81750r201
Tip: Access positions for across all investors
Analyze quarterly positions in Seres Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seres Therapeutics stock
Who bought or sold Seres Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Flagship Ventures Management | 1.2M | $22M | 0% | Sep 2025 |
|
| Susquehanna International | 393k | $7.6M | 250% | Sep 2025 |
|
| Vanguard Group | 312k | $6.0M | 7% | Sep 2025 |
|
| Marshall Wace | 126k | $2.4M | 37% | Sep 2025 |
|
| Hudson Bay Capital Management | 125k | $2.4M | 100% | Sep 2025 |
|
| BlackRock | 102k | $2.0M | 1% | Sep 2025 |
|
| Vontobel Holding | 99k | $1.9M | 23% | Sep 2025 |
|
| J. Goldman & Co | 89k | $1.7M | 100% | Sep 2025 |
|
| Citadel Advisors | 85k | $1.6M | 695% | Sep 2025 |
|
| Geode Capital Management | 85k | $1.6M | -7% | Sep 2025 |
|
| Caption Management | 75k | $1.4M | 100% | Sep 2025 |
|
| Jane Street | 68k | $1.3M | 100% | Sep 2025 |
|
| Charles Schwab Investment Management | 31k | $604k | -10% | Sep 2025 |
|
| State Street Corporation | 30k | $572k | 11% | Sep 2025 |
|
| Schonfeld Strategic Advisors | 29k | $557k | 100% | Sep 2025 |
|
| Lion Point Capital | 27k | $522k | 59% | Sep 2025 |
|
| Centiva Capital | 25k | $481k | 100% | Sep 2025 |
|
| UBS Group | 13k | $244k | 68% | Sep 2025 |
|
| Belvedere Trading | 12k | $235k | 100% | Sep 2025 |
|
| Northern Trust | 12k | $233k | -20% | Sep 2025 |
|
| Invesco | 10k | $201k | 100% | Sep 2025 |
|
| Morgan Stanley | 7.8k | $87k | 100% | Jun 2025 |
|
| SBI Securities | 3.5k | $67k | 0% | Sep 2025 |
|
| Simplex Trading | 2.8k | $54k | 100% | Sep 2025 |
|
| FMR | 1.9k | $36k | -99% | Sep 2025 |
|
| Barclays | 1.4k | $27k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 296.00 | $5.8k | -96% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 212.00 | $4.1k | -30% | Sep 2025 |
|
| UMA Financial Services | 142.00 | $2.7k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 65.00 | $1.3k | 100% | Sep 2025 |
|
| Us Bancorp | 12.00 | $231.000000 | -52% | Sep 2025 |
|
| Wells Fargo & Company | 10.00 | $192.000000 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 8.00 | $151.000000 | 0% | Sep 2025 |
|
| Sound Income Strategies | 8.00 | $156.000000 | 100% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 3.00 | $57.999900 | 100% | Sep 2025 |
|
| SRS Capital Advisors | 2.00 | $38.000000 | 100% | Sep 2025 |
|
Who sold out of Seres Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2025 | 22k | $249k |
| Squarepoint Ops | Jun 2025 | 21k | $232k |
| Wolverine Trading | Jun 2025 | 16k | $143k |
| Tang Capital Management | Jun 2025 | 14k | $155k |
| Bridgeway Capital Management | Jun 2025 | 13k | $139k |
| Group One Trading | Jun 2025 | 1.2k | $13k |
| Union Bankshares | Jun 2025 | 411.00 | $4.6k |
| Tower Research Capital | Jun 2025 | 185.00 | $2.1k |
| Raymond James Financial | Jun 2025 | 56.00 | $625.335200 |